Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response
Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The primary aim is to show whether a reduction in tumor related mRNAs and a panel of selected
miRNAS can be used to personalize enzalutamide therapy.
Furthermore the aim is to explore the relation between drug exposure and the decrease in the
selected biomarkers and treatment response.